|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mohammed AA and El-Shentenawy A: Advanced
thyroid cancers: New era of treatment. Med Oncol. 31:492014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Herbst RS: Review of epidermal growth
factor receptor biology. Int J Radiat Oncol Biol Phys. 59 Suppl
2:S21–S26. 2004. View Article : Google Scholar
|
|
4
|
Hsu F, Nichol A, Toriumi T and De Caluwe
A: Miliary metastases are associated with epidermal growth factor
receptor mutations in non-small cell lung cancer: A
population-based study. Acta Oncol. 56:1175–1180. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cao WM, Gao Y and Wang XJ: Lack of
epidermal growth factor receptor (EGFR)-activating mutations in
triple-negative breast cancer in china. Breast Cancer Res.
17:1152015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tanaka Y, Terai Y, Tanabe A, Sasaki H,
Sekijima T, Fujiwara S, Yamashita Y, Kanemura M, Ueda M, Sugita M,
et al: Prognostic effect of epidermal growth factor receptor gene
mutations and the aberrant phosphorylation of Akt and ERK in
ovarian cancer. Cancer Boil Ther. 11:50–57. 2011. View Article : Google Scholar
|
|
7
|
Mallick UK and American Thyroid A: The
revised American Thyroid Association management guidelines 2009 for
patients with differentiated thyroid cancer: An evidence-based
risk-adapted approach. Clin Oncol (R Coll Radiol). 22:472–474.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tong D, Liang YN, Stepanova AA, Liu Y, Li
X, Wang L, Zhang F and Vasilyeva NV: Increased Eps15 homology
domain 1 and RAB11FIP3 expression regulate breast cancer
progression via promoting epithelial growth factor receptor
recycling. Tumour Biol. 39:10104283176910102017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang S, Wang N, Zheng Y, Zhang J, Zhang F
and Wang Z: Caveolin-1: An oxidative stress-related target for
cancer prevention. Oxid Med Cell Longev. 2017:74540312017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nwosu ZC, Ebert MP, Dooley S and Meyer C:
Caveolin-1 in the regulation of cell metabolism: A cancer
perspective. Mol Cancer. 15:712016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Moreno-Caceres J, Caja L, Mainez J,
Mayoral R, Martín-Sanz P, Moreno-Vicente R, Del Pozo MÁ, Dooley S,
Egea G and Fabregat I: Caveolin-1 is required for TGF-β-induced
transactivation of the EGF receptor pathway in hepatocytes through
the activation of the metalloprotease TACE/ADAM17. Cell Death Dis.
5:e13262014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu L, Qu X, Li H, Li C, Liu J, Zheng H and
Liu Y: Src/caveolin- 1-regulated EGFR activation antagonizes
TRAIL-induced apoptosis in gastric cancer cells. Oncol Rep.
32:318–324. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang J, Naslavsky N and Caplan S: Rabs
and EHDs: Alternate modes for traffic control. Biosci Rep.
32:17–23. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Grant BD and Caplan S: Mechanisms of
EHD/RME-1 protein function in endocytic transport. Traffic.
9:2043–2052. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Butterworth MB, Edinger RS, Silvis MR,
Gallo LI, Liang X, Apodaca G, Frizzell RA and Johnson JP: Rab11b
regulates the trafficking and recycling of the epithelial sodium
channel (ENaC). Am J Physiol Renal Physiol. 302:F581–F590. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bhuin T and Roy JK: Rab11 in disease
progression. Int J Mol Cell Med. 4:1–8. 2015.PubMed/NCBI
|
|
17
|
Vetter M, Stehle R, Basquin C and
Lorentzen E: Structure of Rab11-FIP3-Rabin8 reveals simultaneous
binding of FIP3 and Rabin8 effectors to Rab11. Nat Struc Mol Boil.
22:695–702. 2015. View Article : Google Scholar
|
|
18
|
Takahashi S, Takei T, Koga H, Takatsu H,
Shin HW and Nakayama K: Distinct roles of Rab11 and Arf6 in the
regulation of Rab11-FIP3/arfophilin-1 localization in mitotic
cells. Genes Cells. 16:938–950. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Collins LL, Simon G, Matheson J, Wu C,
Miller MC, Otani T, Yu X, Hayashi S, Prekeris R and Gould GW:
Rab11-FIP3 is a cell cycle-regulated phosphoprotein. BMC Cell Boil.
13:42012. View Article : Google Scholar
|
|
20
|
Iaea DB, Mao S, Lund FW and Maxfield FR:
Role of STARD4 in sterol transport between the endocytic recycling
compartment and the plasma membrane. Mol Biol Cell. 28:1111–1122.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chung BM, Tom E, Zutshi N, Bielecki TA,
Band V and Band H: Nexus of signaling and endocytosis in
oncogenesis driven by non-small cell lung cancer-associated
epidermal growth factor receptor mutants. World J Clin Oncol.
5:806–823. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gao Y, Wang Y, Sun L, Meng Q, Cai L and
Dong X: Expression of TGFβ-1 and EHD1 correlated with survival of
non-small cell lung cancer. Tumour Biol. 35:9371–9380. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Meng Q, Xing Y, Ren T, Lu H, Xi Y, Jiang
Z, Hu J, Li C, Sun L, Sun D and Cai L: Mammalian Eps15 homology
domain 1 promotes metastasis in non-small cell lung cancer by
inducing epithelial-mesenchymal transition. Oncotarget.
8:22433–22442. 2017.PubMed/NCBI
|
|
24
|
Hoop CL, Sivanandam VN, Kodali R, Srnec MN
and van der Wel PC: Structural characterization of the caveolin
scaffolding domain in association with cholesterol-rich membranes.
Biochemistry. 51:90–99. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee YM and Lee JB: Prognostic value of
epidermal growth factor receptor, p53 and galectin-3 expression in
papillary thyroid carcinoma. J Int Med Res. 41:825–834. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Paskas S, Jankovic J, Marecko I, Išić
Denčić T, Tatić S, Cvejić D and Savin S: Caveolin-1 expression in
papillary thyroid carcinoma: Correlation with clinicopathological
parameters and BRAF mutation status. Otolaryngol Head Neck Surg.
150:201–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen D, Qi W, Zhang P, Guan H and Wang L:
Expression of the estrogen receptor α, progesterone receptor and
epidermal growth factor receptor in papillary thyroid carcinoma
tissues. Oncol Lett. 10:317–320. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tang C, Yang L, Wang N, Li L, Xu M, Chen
GG and Liu ZM: High expression of GPER1, EGFR and CXCR1 is
associated with lymph node metastasis in papillary thyroid
carcinoma. Int J Clin Exp Pathol. 7:3213–3223. 2014.PubMed/NCBI
|
|
29
|
Gidon A, Bardin S, Cinquin B, Boulanger J,
Waharte F, Heliot L, de la Salle H, Hanau D, Kervrann C, Goud B and
Salamero J: A Rab11A/myosin Vb/Rab11-FIP2 complex frames two late
recycling steps of langerin from the ERC to the plasma membrane.
Traffic. 13:815–833. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Naslavsky N, Rahajeng J, Sharma M, Jovic M
and Caplan S: Interactions between EHD proteins and Rab11-FIP2: A
role for EHD3 in early endosomal transport. Mol Boil Cell.
17:163–177. 2006. View Article : Google Scholar
|
|
31
|
Horgan CP, Oleksy A, Zhdanov AV, Lall PY,
White IJ, Khan AR, Futter CE, McCaffrey JG and McCaffrey MW:
Rab11-FIP3 is critical for the structural integrity of the
endosomal recycling compartment. Traffic. 8:414–430. 2007.
View Article : Google Scholar : PubMed/NCBI
|
